BRGX (BioRegenx) ROCE % : -9.24% (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BioRegenx's annualized ROCE % for the quarter that ended in Sep. 2024 was -9.24%.

BioRegenx ROCE % Historical Data

The historical data trend for BioRegenx's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx ROCE % Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-107.73

-75.00

-144.44

BioRegenx Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-	-	-145.42	-26.30	-9.24

BioRegenx ROCE % Calculation

BioRegenx's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.563	/	( ( (0.059 - 0.065)	+	(0.032 - 0.254) )	/ 2 )
	=	-0.563	/	( (-0.006	+	-0.222)	/ 2 )
	=	-0.563	/	-0.114
	=	493.86 %

BioRegenx's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-1.308	/	( ( (17.891 - 3.42)	+	(17.361 - 3.518) )	/ 2 )
	=	-1.308	/	( ( 14.471	+	13.843 )	/ 2 )
	=	-1.308	/	14.157
	=	-9.24 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

BioRegenx (OTCPK:BRGX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BioRegenx ROCE % Related Terms

Thank you for viewing the detailed overview of BioRegenx's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7407 Ziegler Road, Chattanooga, TN, USA, 37421

Website

https://www.bioregenx.com

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.